Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript
Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript
Journey Medical Corporation ( DERM ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Jaclyn Jaffe - Senior Director of Corporate Operations Claude Maraoui - Founder, President, CEO & Director Joseph Benesch - CFO & Corporate Controller Ramsey Alloush - COO, General Counsel & Company Secretary Conference Call Participants Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division Scott Henry - Alliance Global Partners, Research Division Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Mayank Mamtani - B.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Joseph Castro Nuveen LLC | 24,034 | $151,837.4 | $174,967.52 | $23,130.12 | 15.23% |
Alexandra Stickelman Root Financial Partners, LLC | 2 | $9 | $14.36 | $5.36 | 59.56% |
Mark Schafer Police & Firemen's Retirement System of New Jersey | 4,002 | $28,734 | $28,274.13 | -$459.87 | -1.6% |
| Specialty Retail Industry | Consumer Discretionary Sector | Claude Maraoui CEO | NASDAQ (CM) Exchange | 48115J109 CUSIP |
| US Country | 58 Employees | - Last Dividend | - Last Split | - IPO Date |
Journey Medical Corporation, initially known as Coronado Dermatology, Inc., is a healthcare enterprise that has dedicated its efforts towards the development and commercialization of pharmaceutical products specifically targeted at treating dermatological conditions. Its operational base is in the United States, with its headquarters situated in Scottsdale, Arizona. Journey Medical Corporation functions as a subsidiary of Fortress Biotech, Inc., and has been in operation since its incorporation in the year 2014. The company has carved out a niche for itself in the dermatology domain by offering an array of treatment solutions ranging from medicated cloths for hyperhidrosis to oral and topical medications for acne and rosacea, among others.